ESTHER HAMBRICK: Open Payments
NPI 1861019697 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,473 in 144 payments from 24 companies in 2025. Trend: 2023 $1,282 · 2024 $2,446 · 2025 $3,473
Food & beverage: $3,473
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $492 |
| Insmed, Inc. | 20 | $440 |
| Regeneron Healthcare Solutions, Inc. | 15 | $382 |
| GlaxoSmithKline, LLC. | 19 | $302 |
| AstraZeneca Pharmaceuticals LP | 9 | $253 |
| Grifols USA, LLC | 9 | $250 |
| Pulmonx Corporation | 1 | $157 |
| Verona Pharma, Inc. | 7 | $151 |
| Actelion Pharmaceuticals US, Inc. | 2 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $121 |
Products named: DUPIXENT, Arikayce, Prolastin-C Liquid, TRELEGY ELLIPTA, AIRSUPRA, CHARTIS CATHETER, Ohtuvayre, UPTRAVI.
Industry payments across AL — which companies pay providers there.
